 |
인쇄하기
취소
|
Re-assessment of drugs’ economic effectiveness should be reserved, KPMA says
The government will have to delay its re-assessment plan over 3,000 medicines this year in the midst of business downturn, the Korea Pharmaceutical Manufacturers Association said in a statement.
In the statement co-signed by 100 pharmaceutical firms, which was delivered to the Ministry of Health, Welfare and Family Affairs, the association claimed that the plan will fatally damage their earn...
In the statement co-signed by 100 pharmaceutical firms, which was delivered to the Ministry of Health, Welfare and Family Affairs, the association claimed that the plan will fatally damage their earn...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.